Home / People / Gabriela Staber
Gabriela-Staber-CMS-AT

Gabriela Staber

Partner
Attorney-at-law for Life Sciences

CMS Reich-Rohrwig Hainz
Rechtsanwälte GmbH
Gauermanngasse 2
1010 Vienna
Austria
Languages German, English
Life Sciences & Healthcare

Specialisation in Life Sciences & Healthcare

Gabriela Staber is an attorney-at-law specialising in intellectual property and unfair competition law with a sector focus on life sciences & healthcare and TMC (technology, media & telecommunications).  She advises on issues related to the marketing and distribution of pharmaceuticals and medical devices as well as the protection of intellectual property. Her expertise includes advertising and product labelling, compliance, restructuring of distribution systems, reimbursement / market access, clinical trials, licensing, counterfeits and parallel imports and dispute resolution.

Industries

Her clients include pharmaceutical, medical device and biotechnology companies, healthcare start-ups and online pharmacies.

Publications and lectures

Gabriela Staber regularly publishes in specialist journals. She has co-authored of commentaries on the European Union Trademark Regulation and the Community Design Regulation, as well as contributing to the publication Distribution & Marketing of Drugs. She regularly lectures and holds trainings in the abovementioned fields.

Ranking

Gabriela Staber was named “often recommended” in JUVE 2019 for IP and Regulatory.

more less

Education

  • 2011 – Bar admission in New York and Massachusetts
  • 2010 – LL.M. in Intellectual Property and Information Technology Law & U.S. Law, Suffolk Law School (Boston)
  • 2007 – Bar admission in Austria
  • 2004 – Doctor iuris in Commercial Law (Antitrust Law), University of Vienna
  • 2001 – LL.M. in European Law, King’s College London
  • 1999 – Master of Laws, University of Vienna
more less

Publications

  • Hasselblatt, European Union Trademark Regulation (2nd edition 2018), co-author
  • Hasselblatt, Community Design Trade Mark Regulation (2nd edition 2018), co-author
  • Distribution & Marketing of Drugs (third edition 2018), co-author
more less
Intellectual Property

Specialisation in intellectual property law

Gabriela Staber is an attorney-at-law specialising in intellectual property and unfair competition law with a sector focus on life sciences & healthcare and TMC (technology, media & telecommunications).  In addition to dispute resolution, her expertise includes criminal prosecution of infringements, licensing of intellectual property rights, negotiation of cross-border and international agreements, protection of designs, know-how and trade secrets, management of trademark portfolios, employee inventions, software, advertising and product labelling as well as antitrust issues in connection with intellectual property rights.

Industries

Gabriela Staber advises clients from all industries with a special focus on life sciences & healthcare, consumer goods, technology and media.

Publications and lectures

Gabriela Staber regularly gives lectures and training courses in the above-mentioned fields. She regularly publishes in specialist journals and is co-author of commentaries on the European Union Trademark Regulation and the Community Design Regulation.

Ranking

Gabriela Staber was named “often recommended” in JUVE 2019 for IP and Regulatory.

more less

Education

  • 2011 – Bar admission in New York and Massachusetts
  • 2010 – LL.M. in Intellectual Property and Information Technology Law & U.S. Law, Suffolk Law School (Boston)
  • 2007 – Bar admission in Austria
  • 2004 – Doctor iuris in Commercial Law (Antitrust Law), University of Vienna
  • 2001 – LL.M. in European Law, King’s College London
  • 1999 – Master of Laws, University of Vienna
more less

Publications

  • Hasselblatt, European Union Trademark Regulation (2nd edition 2018), co-author
  • Hasselblatt, Community Design Trade Mark Regulation (2nd edition 2018), co-author
  • Distribution & Marketing of Drugs (third edition 2018), co-author
more less
TMC - Technology, Media & Communications

Specialisation in TMC (technology, media & telecommunications)

Gabriela Staber is an attorney-at-law specialising in intellectual property and unfair competition law with a sector focus on life sciences & healthcare and TMC (technology, media & telecommunications).  Her practice areas include television, telecommunications, new media and sports. Her expertise comprises the marketing of media rights, short reports, regulatory broadcasting and telecommunications law, advertising, licensing, copyright protection of media content, trademark law, protection of personal rights as well as reputation management and litigation and proceedings before regulatory authorities in these areas.

Industries

Her clients include broadcasters, major sports event organisers, media companies and telecommunications companies.

Publications and lectures

Gabriela Staber regularly gives lectures and training courses in the above-mentioned fields and publishes regularly in specialist journals. She is co-author of commentaries on the European Union Trademark Regulation and the Community Design Regulation.

Ranking

Gabriela Staber was named “often recommended” in JUVE 2019 for IP and Regulatory.

more less

Education

  • 2011 – Bar admission in New York and Massachusetts
  • 2010 – LL.M. in Intellectual Property and Information Technology Law & U.S. Law, Suffolk Law School (Boston)
  • 2007 – Bar admission in Austria
  • 2004 – Doctor iuris in Commercial Law (Antitrust Law), University of Vienna
  • 2001 – LL.M. in European Law, King’s College London
  • 1999 – Master of Laws, University of Vienna
more less

Publications

  • Hasselblatt, European Union Trademark Regulation (2nd edition 2018), co-author
  • Hasselblatt, Community Design Trade Mark Regulation (2nd edition 2018), co-author
  • Distribution & Marketing of Drugs (third edition 2018), co-author
more less

Feed

Show only
20/03/2020
In­tel­lec­tu­al Prop­erty Of­fices in Europe and Aus­tria...
20 Mar 20
In­tel­lec­tu­al Prop­erty Of­fices in Europe and Aus­tria take meas­ures...
Europe is in the grip of the COV­ID-19 vir­us: Spain has de­clared a state of emer­gency and Ger­many is also tak­ing re­strict­ive meas­ures against the spread of the corona vir­us. Now the European Uni­on In­tel­lec­tu­al...
28 Jan 20
CMS ad­vised GRAPHA-Hold­ing AG on the ac­quis­i­tion of...
25 Feb 20
Data Pro­tec­tion vs Un­fair Com­pet­i­tion Law: Round 1
The ques­tion wheth­er com­pet­it­ors or as­so­ci­ations can bring a claim for vi­ol­a­tion of un­fair com­pet­i­tion law in case of in­fringe­ments of the GDPR is cur­rently on the agenda of the courts of nu­mer­ous coun­tries....
16/10/2019
New Ob­lig­a­tions for So­cial Plat­forms
15 Nov 19
New Ob­lig­a­tions for So­cial Plat­forms
So­cial me­dia has be­come in­dis­pens­able for the ex­change of in­form­a­tion on the In­ter­net. On plat­forms where user-gen­er­ated con­tent is in the fore­ground, users are fre­quently en­coun­ter­ing ra­cist, sex­ist...
25 June 2019
AI in Life Sci­ences
Leg­al per­spect­ives on the op­por­tun­it­ies and chal­lenges...
05 Aug 19
Aus­tria - Are doc­tors al­lowed to ap­ply non-con­ven­tion­al treat­ments?
In a re­cent de­cision the Aus­tri­an Su­preme Ad­min­is­trat­ive Court for the first time has set out un­der which con­di­tions non-con­ven­tion­al treat­ment that has not been eval­u­ated in clin­ic­al stud­ies may con­sti­tute...
16/04/2019
CMS ad­vises AL­PLA on joint ven­ture in Den­mark re­gard­ing...
01/03/2019
BREXIT: What do phar­ma­ceut­ic­al and med­ic­al device com­pan­ies...
04/12/2018
CMS Busi­ness Break­fast: Ready for the new trade secrets...
17/05/2018
Dis­tri­bu­tion and mar­ket­ing of drugs in Aus­tria: over­view
A Q&A guide to dis­tri­bu­tion and mar­ket­ing of drugs...